Learn Mode

BRKR - Bruker Corp

29

$34.31

$0.59 (1.750%)

At close: 3/30/26, 8:00 PM

Score

2.81/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

BRKR

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$5.22B

Industry

Life Sciences Tools & Services

EPS (TTM)

-$0.15

P/E (TTM)

0.00

Div & Yield

$0.20 (0.58%)

FCF Payout Ratio

214.39%

P/S (TTM)

1.52

P/B

2.13

Diluted Shares

152.10M

Ex-Dividend

2026-03-23

Next Earnings

05-05

Forward P/E

15.86

Payout Ratio

0.00%

P/FCF (TTM)

367.79

FCF Yield

0.27%

Earnings Yield

-0.43%

52 Week Range

Score Card

Explore Scores Tab

2.81

Average

Bruker Corp has grown revenue at 2.08% over the past year, which suggests sales are increasing. Also, it has seen its revenue increase by 2.08% over the past year, which suggests sales are growing modestly.

Valuation Model

Key Score

1.00

Very Bad

Management

5.00

Very Good

Growth

3.00

Average

Profitability

5.00

Very Good

Fin. Health

5.00

Very Good

Dividends

4.00

Good

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 16:44:08

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-16 16:15:12

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-13 16:19:17

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-06 11:45:25

Form S-8 POS

Securities to be offered to employees in employee benefit plans, post-effective amendments

Filed on 2026-02-27 17:10:40

Form S-8

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Filed on 2026-02-27 17:09:36

Form 10-K

Annual financials report pursuant to Section 13 or 15(d)

Filed on 2026-02-27 16:04:32

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-02-20 16:38:42

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-18 16:38:51

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-18 16:15:26

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-18 16:15:23

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-18 16:15:22

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$73.50

114.2%

Avg:

$49.93

45.5%

Low:

$35.35

3.0%

(% change is relative to the current stock price: $34.31)

Analyst Recommendations

Go to Analyst Tab

3.95

Good

32%

Strong Buy (7)

36%

Buy (8)

27%

Hold (6)

Sell (1)

Strong Sell (0)

About

Website
https://www.bruker.com/
Address
40 Manning Rd, Billerica MASSACHUSETTS, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1109354

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

IPO Date

2000-08-04

Industry

Life Sciences Tools & Services

Total Employees

11,085

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences

BRKR - Bruker Corp

29

$34.31

$0.59 (1.750%)

2.81/5

Stock Unlock

Stock Profile

Score Card

Average

Insider Transactions

Market News

Form SCHEDULE 13G/A

Filed on 2026-03-26 16:44:08

Form 4

Filed on 2026-03-16 16:15:12

Form 144

Filed on 2026-03-13 16:19:17

Form SCHEDULE 13G/A

Filed on 2026-03-06 11:45:25

Form S-8 POS

Filed on 2026-02-27 17:10:40

Form S-8

Filed on 2026-02-27 17:09:36

Form 10-K

Filed on 2026-02-27 16:04:32

Form 8-K

Filed on 2026-02-20 16:38:42

Form 4

Filed on 2026-02-18 16:38:51

Form 4

Filed on 2026-02-18 16:15:26

Form 4

Filed on 2026-02-18 16:15:23

Form 4

Filed on 2026-02-18 16:15:22

Financials

Price Targets

114.2%

45.5%

3.0%

Analyst Recommendations

About

Similar Stocks